As federal officials move to reclassify cannabis from a Schedule I to a Schedule III drug, University of Michigan experts say the shift could open the door to more rigorous research on a substance millions of Americans already use. The article examines why the policy change matters and why scientific evidence has struggled to keep pace with public perception.
What Does Cannabis ‘Rescheduling’ Mean for Science and Society?
Jan. 9, 2026
•
Read time: 5-15 mins
Share: